Business Context and Reporting Period
This Form 8-K Current Report was filed by Atomera Incorporated on May 28, 2019. The Company, an emerging growth company incorporated in Delaware, is headquartered in Los Gatos, California, and its common stock trades on the Nasdaq Capital Market under the symbol "ATOM". The report primarily addresses a material definitive agreement entered into on the date of the report.
Key Financial Metrics and Transaction Details
The filing details a registered direct offering of common stock. Key transaction metrics include:
- Shares Issued: 1,675,000 shares of common stock.
- Offering Price: $4.00 per share.
- Expected Gross Proceeds: Approximately $6.7 million (before placement agent fees and offering expenses).
- Placement Agent: National Securities Corporation (wholly-owned subsidiary of National Holdings Corporation).
- Expected Closing Date: On or about May 30, 2019.
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity metrics for the reporting period, as this is a transaction-specific report rather than a periodic financial statement.
Material Changes and Outlook
The primary material change is the execution of a Securities Purchase Agreement with seven institutional and accredited investors. The Company intends to use the proceeds from this offering for general corporate purposes, though specific allocation details are not provided in this text. The transaction is subject to customary closing conditions.
Management commentary is limited to the announcement of the offering via a press release dated May 29, 2019, which is incorporated by reference. No specific forward-looking guidance regarding future revenue or earnings is contained within this document.
Investor Verification Checklist
- Verify the final closing of the offering and the actual net proceeds received after deducting placement agent fees and expenses.
- Review the attached Securities Purchase Agreement (Exhibit 10.1) for specific covenants, representations, and termination provisions.
- Confirm the issuance of the prospectus supplement filed on or about May 29, 2019.
- Assess the dilution impact of the 1,675,000 new shares on existing shareholders.
- Monitor the Company's cash position post-closing to evaluate liquidity improvements.